Gain of chromosome 1q21 is an independent adverse prognostic factor in light chain amyloidosis patients treated with melphalan/dexamethasone - Bochtler, Tilmann; Hegenbart, Ute; Seckinger, Anja; Dietrich, Sascha; Granzow, Martin; Neben, Kai; Goldschmidt, Hartmut; Ho, Anthony Dick; Hose, Dirk; Jauch, Anna; Schönland, Stefan (Amyloid, 2014)
Gesehen am 26.01.2016